Cargando…
Targeting HDAC6 to Overcome Autophagy-Promoted Anti-Cancer Drug Resistance
Histone deacetylases (HDACs) regulate gene expression through the epigenetic modification of chromatin structure. HDAC6, unlike many other HDACs, is present in the cytoplasm. Its deacetylates non-histone proteins and plays diverse roles in cancer cell initiation, proliferation, autophagy, and anti-c...
Autores principales: | Jo, Hyein, Shim, Kyeonghee, Jeoung, Dooil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455701/ https://www.ncbi.nlm.nih.gov/pubmed/36076996 http://dx.doi.org/10.3390/ijms23179592 |
Ejemplares similares
-
HDAC2 as a target for developing anti-cancer drugs
por: Jo, Hyein, et al.
Publicado: (2023) -
Roles of RNA Methylations in Cancer Progression, Autophagy, and Anticancer Drug Resistance
por: Jo, Hyein, et al.
Publicado: (2023) -
Potential of the miR-200 Family as a Target for Developing Anti-Cancer Therapeutics
por: Jo, Hyein, et al.
Publicado: (2022) -
Cancer/Testis Antigens as Targets for RNA-Based Anticancer Therapy
por: Shim, Kyeonghee, et al.
Publicado: (2023) -
The Potential of Senescence as a Target for Developing Anticancer Therapy
por: Jo, Hyein, et al.
Publicado: (2023)